en · de · es · fr · pt
cjc-1295-notes.peptides9002.com › Info › Albumin Binding And Duration Of Action — Evidence Review

Albumin Binding And Duration Of Action — Evidence Review

By Editorial Desk · published 2025-10-11 · last reviewed 2025-11-21 · Info

This is a working overview of somatotroph, written for readers who want more than a one-paragraph summary but less than a textbook.

This page was last updated on 2025-11-21 and is reviewed periodically as new material appears.

Albumin Binding and Duration of Action

Enzymatic protection is a separate mechanism from plasma protein binding. The four substitutions in the backbone reduce recognition by dipeptidyl peptidase IV, which normally cleaves the natural hormone within minutes. Without the reactive group, this resistance still yields only a short window of activity, generally reported in the range of tens of minutes. With it, reported half-lives in early human work extended to several days. The size of that gap is the main practical distinction between the two materials.

Both forms act at the pituitary receptor for growth hormone-releasing hormone and increase growth hormone output, which in turn raises insulin-like growth factor 1. A long-acting analog produces sustained rather than pulsatile stimulation, and the physiological consequences of that pattern are not fully settled. Published human data on the extended form remain limited, and much of what circulates in discussion traces to early company reports rather than independent replication. How sustained exposure affects normal feedback remains an open question.

The distinguishing feature of the DAC form is a maleimide-containing group that reacts with the free thiol of cysteine-34 on human serum albumin. This reaction forms a covalent bond without enzymatic assistance, and it takes place after the peptide enters the bloodstream. Because albumin is abundant and long-lived, the attached peptide is carried through circulation far longer than an unmodified fragment would survive. The chemistry is a deliberate pharmacokinetic strategy rather than a change to receptor activity.

Structure And Receptor Pharmacology

Receptor level activity follows the canonical GHRH pathway. The peptide binds the GHRH receptor, a class B G protein coupled receptor on somatotroph cells of the anterior pituitary. Binding raises intracellular cyclic AMP, which promotes calcium entry and the release of growth hormone into the bloodstream. Because the molecule acts at the same receptor as the endogenous hormone, its effect is superimposed on the natural pulsatile rhythm rather than replacing it. Whether sustained receptor occupation leads to desensitization is not fully settled.

CJC-1295 belongs to a class of synthetic peptides modeled on growth hormone releasing hormone, a forty-four amino acid signal produced by the hypothalamus. The compound is built from the first twenty-nine residues of the natural sequence, with four substitutions introduced at positions 2, 8, 15 and 27. These changes were designed to slow enzymatic breakdown while preserving receptor activation. The result is a peptide that is shorter than native GHRH and considerably more resistant to ordinary clearance pathways in circulation.

Two related forms appear under the CJC-1295 name. The simpler analogue, commonly written as modified GRF(1-29), carries the four substitutions but no additional conjugation. The second form attaches a maleimidopropionic acid linker to a lysine residue, a modification frequently called the drug affinity complex. That linker reacts with the free thiol on serum albumin to form a covalent bond. Because albumin has a long residence time in blood, the conjugated peptide stays in circulation far longer than the unconjugated analogue.

Cjc-1295 at a glance

PropertyValueNotes
Duration with linkerSeveral daysReported in early human work
Duration without linkerTens of minutesShort plasma residence
Albumin attachment siteCysteine-34Covalent maleimide reaction
Primary receptorPituitary GHRH receptorStimulates growth hormone release
Downstream markerInsulin-like growth factor 1Indirect measure of activity

Receptor Action and Clearance

Clearance profiles diverge sharply between the two versions. The albumin-binding molecule stays in plasma for several days, whereas the unmodified analog is largely gone within about half an hour in reported work. Cleavage by dipeptidyl peptidase IV is a major contributor to the short life of the unmodified sequence. These gaps mean the two versions cannot be substituted for each other in study design or in reading results side by side.

Reports on this compound commonly follow serum growth hormone and insulin-like growth factor 1 across defined time windows. Protocols differ in sampling frequency, assay platform, and participant characteristics, which makes direct comparison between publications difficult. Some work focuses on pulsatile release patterns instead of average concentrations. Whether repeated exposure alters endogenous hormone rhythms over long periods remains an open question, and the formal literature is thinner than the volume of informal commentary implies.

Related pages on this site

Mechanism and Pharmacokinetics

Binding of the peptide to the growth hormone-releasing hormone receptor on pituitary somatotrophs triggers a G protein coupled cascade that raises cyclic AMP and opens calcium channels. The result is greater secretion of growth hormone into the bloodstream. Because the peptide acts at the same receptor as the natural hypothalamic hormone, its effect is amplified pulse size rather than an entirely separate release pathway. Receptor binding alone does not determine the response, since somatostatin tone and other inputs modulate the final output.

The albumin-binding version stays in circulation for days, because covalent attachment to serum albumin shields the peptide from rapid filtration and degradation. Reported half-lives for this form fall in the range of several days. The version without the linker is cleared in minutes, with estimates often near thirty minutes in animal work. These figures come from small studies and vary with assay method, species, and route, so they are best read as approximate rather than fixed constants.

Background and Molecular Design

CJC-1295 belongs to a family of synthetic peptides modeled on growth hormone-releasing hormone, the hypothalamic signal that prompts the pituitary to release growth hormone. The compound is built from the first twenty-nine amino acids of the natural human sequence, a fragment that retains full receptor binding capacity. Native growth hormone-releasing hormone is degraded quickly in circulation, so the fragment alone has limited practical value. Early work therefore focused on chemical modifications that preserve receptor binding while slowing enzymatic breakdown. The result is a molecule described in the literature as a long-acting analog of the natural hormone.

Two forms circulate under the CJC-1295 name, and they differ by a single appended group. The version without a drug affinity complex carries four substitutions along the peptide chain, including a D-alanine near the amino terminus and replacements at three other positions. These changes block the enzyme dipeptidyl peptidase IV and remove a methionine residue that is prone to oxidation. The modified fragment is frequently labeled MOD GRF 1-29. Naming conventions are inconsistent across informal sources, which is a common source of confusion.

Reference notes

Advances in the classification of brain cells have been enabled by electrophysiological recording, single-cell genetic sequencing, and high-quality microscopy, which have combined into a single method pipeline called patch-sequencing in which all three methods are simultaneously applied using miniature tools. The efficiency of this method and the large amounts of data that is generated has allowed researchers to make some general conclusions about cell types; for example that the human and mouse brain have different versions of fundamentally the same cell types.

Protein microarrays and high throughput (HT) mass spectrometry (MS) can provide a snapshot of the proteins present in a biological sample. The former approach faces similar problems as with microarrays targeted at mRNA, the latter involves the problem of matching large amounts of mass data against predicted masses from protein sequence databases, and the complicated statistical analysis of samples when multiple incomplete peptides from each protein are detected. Cellular protein localization in a tissue context can be achieved through affinity proteomics displayed as spatial data based on immunohistochemistry and tissue microarrays.

Technetium exits the generator in the form of the pertechnetate ion, TcO4−. The oxidation state of Tc in this compound is +7. This is directly suitable for medical applications only in bone scans (it is taken up by osteoblasts) and some thyroid scans (it is taken up in place of iodine by normal thyroid tissues). In other types of scans relying on 99mTc, a reducing agent is added to the pertechnetate solution to bring the oxidation state of the technecium down to +3 or +4. Secondly, a ligand is added to form a coordination complex. The ligand is chosen to have an affinity for the specific organ to be targeted. For example, the exametazime complex of Tc in oxidation state +3 is able to cross the blood–brain barrier and flow through the vessels in the brain for cerebral blood flow imaging. Other ligands include sestamibi for myocardial perfusion imaging and mercapto acetyl triglycine for MAG3 scan to measure renal function.

Later works of James Prescott Joule, Rudolf Clausius and in particular Ludwig Boltzmann firmly established the kinetic theory of gases and brought attention to both the theories of Bernoulli and Waterston. The debate between proponents of energetics and atomism led Boltzmann to write a book in 1898, which endured criticism until his suicide in 1906. Albert Einstein in 1905 showed how kinetic theory applies to the Brownian motion of a fluid-suspended particle, which was confirmed in 1908 by Jean Perrin.

1RAR trained in Kenya from December 1943 to September 1944, when it transferred to Ceylon and became part of the 22nd (East Africa) Infantry Brigade alongside the 1st KAR and the 3rd Northern Rhodesia Regiment. In December 1944, after three months' training for jungle warfare, 1RAR and the other two components of the brigade joined the Burma Campaign at Chittagong under the command of the 15th Indian Corps. The brigade spent about three months supporting the 25th Indian Division in north-western Burma, advancing through the Mayu peninsula during January 1945 and taking part in the latter stages of the Battle of Ramree Island, landing on the island on 14 February. 1RAR fortified positions at Myinbin, Kyaukkale and Mayin but did not contact Japanese forces. A widespread belief developed among Japanese troops in Burma that the British Army's African soldiers were cannibals, partly because of deliberate disinformation spread by the black troops themselves as they travelled around the country. While entirely unfounded, the notion "that we Africans eat people", as one RAR soldier put it, had a fearsome psychological effect; men of 1RAR reported Japanese soldiers picking up their comrades' bodies in the midst of battle and running away. In March 1945 the 22nd Brigade was ordered south to Dalaba where it became part of the 82nd (West Africa) Division, which had been tasked with clearing the Taungup area of Japanese troops.

Sources: en.wikipedia.org

Reference notes

== Bibliography == Elyse; Houde, Alain (2002). "La PCR en temps réel: principes et applications" (PDF). Reviews in Biology and Biotechnology. 2 (2): 2–11. Archived from the original (PDF) on 2009-06-12. Bustin, SA (2000). "Absolute quantification of mRNA using real-time reverse transcription polymerase chain reaction assays". J Mol Endocrinol. 25 (2): 169–193. doi:10.1677/jme.0.0250169. PMID 11013345. Higuchi, R.; Dollinger, G.; Walsh, P.S.; Griffith, R. (1992). "Simultaneous amplification and detection of specific DNA-sequences". Bio-Technology. 10 (4): 413–417. doi:10.1038/nbt0492-413. PMID 1368485. S2CID 1684150. Holland, P.M.; Abramson, R.D.; Watson, R.; Gelfand, D.H. (1991). "Detection of specific polymerase chain reaction product by utilizing the 50 !30 exonuclease activity of Thermus aquaticus DNA polymerase". Proc. Natl. Acad. Sci. USA. 88 (16): 7276–7280. Bibcode:1991PNAS...88.7276H. doi:10.1073/pnas.88.16.7276. JSTOR 2357665. PMC 52277. PMID 1871133. Kubista, M; Andrade, JM; Bengtsson, M; Forootan, A; Jonak, J; Lind, K; Sindelka, R; Sjoback, R; Sjogreen, B; Strombom, L; Stahlberg, A; Zoric, N (2006). "The real-time polymerase chain reaction". Mol. Aspects Med. 27 (2–3): 95–125. doi:10.1016/j.mam.2005.12.007. PMID 16460794. Higuchi, R.; Fockler, C.; Dollinger, G.; Watson, R. (1993). "Kinetic PCR: Real time monitoring of DNA amplification reactions". Biotechnology. 11 (9): 1026–1030. doi:10.1038/nbt0993-1026. PMID 7764001. S2CID 5714001. Filion, M. (2012). Quantitative Real-time PCR in Applied Microbiology. Caister Academic Press. ISBN 978-1-908230-01-0.

Eileen Dorothy Chambers, Member, Board of Visitors, Her Majesty's Prison and Young Offenders' Institution Drake Hall. For services to Prisoner Welfare. John Theng Keong Chan, Executive Officer, Department of Health. Stephen Victor Chandler, Constable, Metropolitan Police. For services to the Police. Captain Kandiah Chandran, lately Chief Executive, Presentation Housing Association. For services to the Housing Association Movement. Dipakkumar Govindji Chauhan. For services to Community Relations in Tameside, Manchester. Charles Peter Chivers. For services to the community in Cuddington, Cheshire. Alan Leslie Chorley, lately Treasurer, Access Committee for England. For services to disabled people. Celia Ruth Bonham Christie, Founder and Life President, Triumph Over Phobia. For services to the community. William Christie, . For services to the Royal Air Forces Association. Alan Ernest Clark, Senior Executive Officer, Acas, Department of Trade and Industry. Audrey Clark, lately Superintendent Registrar, Gateshead Metropolitan Borough Council. For services to the community. John Clark, Design Engineer, Royal Observatory, Edinburgh. For services to Astronomy. Joan Clarke, General Assistant, Dining Hall, Worcester College of Higher Education. For services to Education. Robert Clarke, Trident Boat Manager, VSEL. For services to the Defence Industry. Stephen Harold Henry Clarke. For services to Archaeology in Monmouth. Margaret Winifred Clarkson. For services to Carlisle Cathedral. Phyllis Mary Coates. For services to the community in Shere, Surrey. Elizabeth Cochrane.

==== Information and Infrastructure Development ==== In 2013, Lad was appointed as Minister of State for Information and Infrastructure Development in the Congress government headed by Chief Minister Siddaramaiah. As minister in charge of Dharwad district, Lad was involved in reviewing district-level development and administrative issues.

Emperor Franz Joseph died of bronchitis and pneumonia at the age of 86 on 21 November 1916. "I remember the dear plump figure of Prince Lobkowitz going up to my husband," Zita later recounted, "and, with tears in his eyes, making the sign of the cross on Charles's forehead. As he did so he said, 'May God bless Your Majesty.' It was the first time we had heard the Imperial title used to us."

Sources: en.wikipedia.org

Frequently asked questions

How does the reactive group attach to albumin?

A maleimide moiety reacts with the thiol of cysteine-34, forming a covalent bond. The reaction occurs in circulation without enzymatic catalysis.

Does the modification change how the peptide signals?

The group is intended to alter distribution and persistence, not receptor engagement. The peptide portion still binds the pituitary receptor, so the primary difference is duration rather than potency.

Are human half-life figures well established?

Not firmly. Early reports describe several days for the extended form, but independent confirmations are sparse, and values vary with assay method and study design.

Is CJC-1295 the same as modified GRF(1-29)?

The names are often used interchangeably in casual writing, but they are not strictly identical. Modified GRF(1-29) refers to the unconjugated analogue carrying only the four substitutions. The version sold as CJC-1295 with DAC includes the albumin binding linker and clears much more slowly.

Network